Survival rate surpasses historical outcomes in a small phase I study ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

All types of brain cancers collectively have a five-year survival rate of just 33%, according to the National Cancer ...

A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...

Jason Collins, the NBA's first openly gay player, who went on to become a pioneer for inclusion and an ambassador for the ...

Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...

Jason Collins, the NBA’s first openly gay player who went on to become a pioneer for inclusion and an ambassador for the ...

According to the National Brain Tumor Society, approximately 1.3 million Americans are living with a brain tumor. The ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive and most common type of primary brain ...

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...

Texas A&M Baseball has partnered with the Mark Massey Legacy Foundation to launch the “Strikeout DMG” initiative during Brain ...